Pronova will be integrated into BASF’s Nutrition & Health division. The combination will enable Pronova to further leverage its leading omega-3 research, product development and manufacturing capabilities through BASF’s global platform and resources.
Gert W Munthe, chairman of the board of directors of Pronova, said: “The proposed combination of Pronova and BASF makes strategic sense. It’s clear that BASF’s global reach and resources, and Pronova’s strong clinical evidence base and manufacturing advantages, would together achieve a leading position in the global omega-3 market.”
Source: Pronova BioPharm ASA
© FoodBev Media Ltd 2024